Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Adults With T1D

NCT: NCT07593625 · NOT_YET_RECRUITING

NCT IDNCT07593625
StatusNOT_YET_RECRUITING
Start Date2026-05-25
Completion2026-08-30

Brief Summary

Single-arm feasibility study to evaluate the safety and feasibility of the Omnipod M System in adults with type 1 diabetes. This study will enroll up to 40 adult participants to have a minimum of 24 participants to initiate the use of the study device. The study will include hotel and outpatient evaluation periods.

Frequently Asked Questions

What is Evaluating Glucose Control Using a Next-Generation AID Algorithm in Adults With T1D?

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Adults With T1D is a clinical trial registered under NCT07593625. Current status: NOT_YET_RECRUITING.

What is the status of NCT07593625?

The current status of NCT07593625 (Evaluating Glucose Control Using a Next-Generation AID Algorithm in Adults With T1D) is: NOT_YET_RECRUITING.

When did Evaluating Glucose Control Using a Next-Generation AID Algorithm in Adults With T1D start?

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Adults With T1D started on 2026-05-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑